Angiodynamics (ANGO) Operating Margin (2016 - 2025)
Historic Operating Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 7.71%.
- Angiodynamics' Operating Margin rose 75200.0% to 7.71% in Q4 2025 from the same period last year, while for Nov 2025 it was 10.59%, marking a year-over-year increase of 726700.0%. This contributed to the annual value of 13.66% for FY2025, which is 496600.0% up from last year.
- Per Angiodynamics' latest filing, its Operating Margin stood at 7.71% for Q4 2025, which was up 75200.0% from 14.07% recorded in Q3 2025.
- Over the past 5 years, Angiodynamics' Operating Margin peaked at 44.52% during Q3 2023, and registered a low of 265.88% during Q1 2024.
- Over the past 5 years, Angiodynamics' median Operating Margin value was 12.47% (recorded in 2021), while the average stood at 23.25%.
- Its Operating Margin has fluctuated over the past 5 years, first plummeted by -2548200bps in 2024, then skyrocketed by 2520300bps in 2025.
- Over the past 5 years, Angiodynamics' Operating Margin (Quarter) stood at 11.09% in 2021, then increased by 14bps to 9.5% in 2022, then tumbled by -75bps to 16.59% in 2023, then grew by 8bps to 15.23% in 2024, then surged by 49bps to 7.71% in 2025.
- Its Operating Margin stands at 7.71% for Q4 2025, versus 14.07% for Q3 2025 and 7.22% for Q2 2025.